In addition to the layoffs, the company is also looking to divest its Infectious Disease Business. Source: BioSpace

Biogen released its third-quarter financials yesterday, showing total revenues of $3.1B for the quarter, a 4 percent gain compared to the same period the previous year. Source: BioSpace

Corbus' stock popped on the release of topline results from a midstage study involving its lead (and only) clinical drug, anabasum. Source: BioSpace

TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace

ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. Source: BioSpace

Immuno-oncology and gene therapy has been a hot field for the last few years, and the approval of the first CAR-T therapies has only set the kindling ablaze. Source: BioSpace

The company is shuttering its GBT440 program to treat idiopathic pulmonary fibrosis (IPF). Source: BioSpace

Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace

The FDA based its decision on data from the COMBI-AD Phase III trial. Source: BioSpace

DBV's share price crumbled over the weekend after its Phase III peanut allergy trial failed to show a statistically significant response against placebo. Source: BioSpace